Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

G. Curigliano; H. J. Burstein; E. P. Winer; M. Gnant; P. Dubsky; S. Loibl; M. Colleoni; M. M. Regan; M. Piccart-Gebhart; H. J. Senn; B. Thürlimann; F. André; J. Baselga; J. Bergh; H. Bonnefoi; S. Y. Brucker; F. Cardoso; L. Carey; E. Ciruelos; J. Cuzick; C. Denkert; A. Di Leo; B. Ejlertsen; P. Francis; V. Galimberti; J. Garber; B. Gulluoglu; P. Goodwin; N. Harbeck; D. F. Hayes; C. S. Huang; J. Huober; H. Khaled; J. Jassem; Z. Jiang; P. Karlsson; M. Morrow; R. Orecchia; K. C. Osborne; O. Pagani; A. H. Partridge; K. Pritchard; J. Ro; E. J.T. Rutgers; F. Sedlmayer; V. Semiglazov; Z. Shao; I. Smith; M. Toi; A. Tutt; G. Viale; T. Watanabe; T. J. Whelan; B. Xu

doi:10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

G. Curigliano
, H. J. Burstein
, E. P. Winer
, M. Gnant
, P. Dubsky
, S. Loibl
, M. Colleoni
, M. M. Regan
, M. Piccart-Gebhart
, H. J. Senn
, B. Thürlimann
, F. André
, J. Baselga
, J. Bergh
, H. Bonnefoi
, S. Y. Brucker
, F. Cardoso
, L. Carey
, E. Ciruelos
, J. Cuzick

C. Denkert, A. Di Leo, B. Ejlertsen, P. Francis, V. Galimberti, J. Garber, B. Gulluoglu, P. Goodwin, N. Harbeck, D. F. Hayes, C. S. Huang, J. Huober, H. Khaled, J. Jassem, Z. Jiang, P. Karlsson, M. Morrow, R. Orecchia, K. C. Osborne, O. Pagani, A. H. Partridge, K. Pritchard, J. Ro, E. J.T. Rutgers, F. Sedlmayer, V. Semiglazov, Z. Shao, I. Smith, M. Toi, A. Tutt, G. Viale, T. Watanabe, T. J. Whelan, B. Xu

Health Science Center

Research output: Contribution to journal › Comment/debate

72 Scopus citations

Abstract

In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

Original language	English
Article number	mdy537
Pages (from-to)	1181
Number of pages	1
Journal	Annals of Oncology
Volume	30
Issue number	7
DOIs	https://doi.org/10.1093/annonc/mdy537
State	Published - 1 Jul 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy537

Fingerprint

Dive into the research topics of 'Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)'. Together they form a unique fingerprint.

Cite this

Curigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H. J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Brucker, S. Y., Cardoso, F., Carey, L., Ciruelos, E., ... Xu, B. (2019). Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Annals of Oncology, 30(7), 1181. Article mdy537. https://doi.org/10.1093/annonc/mdy537

Curigliano, G. ; Burstein, H. J. ; Winer, E. P. et al. / Corrigendum : De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). In: Annals of Oncology. 2019 ; Vol. 30, No. 7. pp. 1181.

@article{95a234f1782640b6b917ad5364426bab,

title = "Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)",

abstract = "In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.",

author = "G. Curigliano and Burstein, \{H. J.\} and Winer, \{E. P.\} and M. Gnant and P. Dubsky and S. Loibl and M. Colleoni and Regan, \{M. M.\} and M. Piccart-Gebhart and Senn, \{H. J.\} and B. Th{\"u}rlimann and F. Andr{\'e} and J. Baselga and J. Bergh and H. Bonnefoi and Brucker, \{S. Y.\} and F. Cardoso and L. Carey and E. Ciruelos and J. Cuzick and C. Denkert and \{Di Leo\}, A. and B. Ejlertsen and P. Francis and V. Galimberti and J. Garber and B. Gulluoglu and P. Goodwin and N. Harbeck and Hayes, \{D. F.\} and Huang, \{C. S.\} and J. Huober and H. Khaled and J. Jassem and Z. Jiang and P. Karlsson and M. Morrow and R. Orecchia and Osborne, \{K. C.\} and O. Pagani and Partridge, \{A. H.\} and K. Pritchard and J. Ro and Rutgers, \{E. J.T.\} and F. Sedlmayer and V. Semiglazov and Z. Shao and I. Smith and M. Toi and A. Tutt and G. Viale and T. Watanabe and Whelan, \{T. J.\} and B. Xu",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

month = jul,

day = "1",

doi = "10.1093/annonc/mdy537",

language = "英语",

volume = "30",

pages = "1181",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "7",

}

Curigliano, G, Burstein, HJ, Winer, EP, Gnant, M, Dubsky, P, Loibl, S, Colleoni, M, Regan, MM, Piccart-Gebhart, M, Senn, HJ, Thürlimann, B, André, F, Baselga, J, Bergh, J, Bonnefoi, H, Brucker, SY, Cardoso, F, Carey, L, Ciruelos, E, Cuzick, J, Denkert, C, Di Leo, A, Ejlertsen, B, Francis, P, Galimberti, V, Garber, J, Gulluoglu, B, Goodwin, P, Harbeck, N, Hayes, DF, Huang, CS, Huober, J, Khaled, H, Jassem, J, Jiang, Z, Karlsson, P, Morrow, M, Orecchia, R, Osborne, KC, Pagani, O, Partridge, AH, Pritchard, K, Ro, J, Rutgers, EJT, Sedlmayer, F, Semiglazov, V, Shao, Z, Smith, I, Toi, M, Tutt, A, Viale, G, Watanabe, T, Whelan, TJ & Xu, B 2019, 'Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)', Annals of Oncology, vol. 30, no. 7, mdy537, pp. 1181. https://doi.org/10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). / Curigliano, G.; Burstein, H. J.; Winer, E. P. et al.
In: Annals of Oncology, Vol. 30, No. 7, mdy537, 01.07.2019, p. 1181.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum

T2 - De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

AU - Curigliano, G.

AU - Burstein, H. J.

AU - Winer, E. P.

AU - Gnant, M.

AU - Dubsky, P.

AU - Loibl, S.

AU - Colleoni, M.

AU - Regan, M. M.

AU - Piccart-Gebhart, M.

AU - Senn, H. J.

AU - Thürlimann, B.

AU - André, F.

AU - Baselga, J.

AU - Bergh, J.

AU - Bonnefoi, H.

AU - Brucker, S. Y.

AU - Cardoso, F.

AU - Carey, L.

AU - Ciruelos, E.

AU - Cuzick, J.

AU - Denkert, C.

AU - Di Leo, A.

AU - Ejlertsen, B.

AU - Francis, P.

AU - Galimberti, V.

AU - Garber, J.

AU - Gulluoglu, B.

AU - Goodwin, P.

AU - Harbeck, N.

AU - Hayes, D. F.

AU - Huang, C. S.

AU - Huober, J.

AU - Khaled, H.

AU - Jassem, J.

AU - Jiang, Z.

AU - Karlsson, P.

AU - Morrow, M.

AU - Orecchia, R.

AU - Osborne, K. C.

AU - Pagani, O.

AU - Partridge, A. H.

AU - Pritchard, K.

AU - Ro, J.

AU - Rutgers, E. J.T.

AU - Sedlmayer, F.

AU - Semiglazov, V.

AU - Shao, Z.

AU - Smith, I.

AU - Toi, M.

AU - Tutt, A.

AU - Viale, G.

AU - Watanabe, T.

AU - Whelan, T. J.

AU - Xu, B.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

AB - In the original article, the disclosure was incomplete. This has now been updated to add the statement for J. Baselga: JBa is on the Board of Directors for Varian Medical Systems, Bristol-Myers Squibb, and is a past board member of Grail. He has performed consulting and/or advisory work for Roche, Lilly, and Novartis. Also, originally the disclosure was part of the Supplementary Material, but this has now been moved to the article. The funding statement has also been updated as follows: JBa was founded by the NIH grant P30CA008748.

UR - https://www.scopus.com/pages/publications/85071164178

U2 - 10.1093/annonc/mdy537

DO - 10.1093/annonc/mdy537

M3 - 评论/辩论

C2 - 30624592

AN - SCOPUS:85071164178

SN - 0923-7534

VL - 30

SP - 1181

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

M1 - mdy537

ER -

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S et al. Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308). Annals of Oncology. 2019 Jul 1;30(7):1181. mdy537. doi: 10.1093/annonc/mdy537

Corrigendum: De-escalating and escalating treatments for early-stage breast cancer: The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28 (1700-1712) DOI: 10.1093/annonc/mdx308)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this